Understanding the causes of congenital dyserythropoietic anemias
The molecular pathophysiology of the congenital dyserythropoietic anemias
This study is looking into congenital dyserythropoietic anemias, which affect how your body makes red blood cells, and it's using cutting-edge tools to find out what causes these issues, with the hope of discovering new treatments for people living with these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11045442 on NIH RePORTER |
What this research studies
This research investigates congenital dyserythropoietic anemias (CDAs), a group of disorders that affect red blood cell production. The team is using advanced techniques, including CRISPR technology, to identify genetic factors that contribute to these conditions. By studying a specific cell line that mimics the disease, they aim to uncover the underlying mechanisms that lead to ineffective red blood cell formation. This could lead to new therapeutic strategies for patients suffering from these anemias.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with congenital dyserythropoietic anemias, particularly those with CDAI or CDAII.
Not a fit: Patients with other forms of anemia not related to congenital dyserythropoietic anemias may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for patients with congenital dyserythropoietic anemias, potentially enhancing their quality of life.
How similar studies have performed: Previous research has shown promise in using CRISPR technology to address genetic disorders, indicating potential for success in this area as well.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Khoriaty, Rami — University of Michigan at Ann Arbor
- Study coordinator: Khoriaty, Rami
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.